白塞氏综合征的免疫剂治疗及免疫指标分析

The Behcet's syndrome's immunizator therapy and immunization target observation

目的： 探讨白塞氏综合征（Ｂｅｈｃｅｔ ｓｙｎｄｒｏｍｅ ，ＢＳ） 临床免疫治疗的药物选择和疗效，以及治疗前后免疫指标的变化。方法： 对１５ 例已确诊为ＢＳ 的患者应用不同的免疫制剂进行治疗，并观察治疗前后外周淋巴细胞绝对值，Ｔｔ％ ，Ｔｒ ％ ，ＩｇＡ，ＩｇＧ，ＩｇＭ ，Ｃ３ 的指标变化。结果： 免疫指标测定支持ＢＳ 为自身免疫性疾病的推论；细胞免疫过程在本症中起了重要作用；体液免疫指标对临床免疫制剂选择具有指导意义。结论： 免疫指标的测定对治疗ＢＳ

Objective:To explore the drug choice of chinical immunization therapy in the Behcet's syndrome and the change of immunization target before and behind treatment.Methods: The concentrations of lymphocyte,Tt%,Tr%,IgA,IgG,IgM,C 3were detected in 15 case BS before and behind treatment.It chase deferent immunizator under treatment.Results: The concentrations support the inference that BS is self immunity desease.Cellular immunity has important action.Humoral immunity target has directive function to choose different immunizator.Conclusion: The measurement of immunization target is good applicable value in treating BS.